Search





Search





Markets
/
Stocks
/
stok
/

Stoke Therapeutics Inc

STOK

Add to Watchlist

29.320USD

+0.020+0.07%

Close 07-27 16:00（ET）Quotes delayed by 15 min

1.73BMarket Cap

LossP/E TTM

Stoke Therapeutics Inc

29.320

+0.020+0.07%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-27

Previous score

10.00

Change

The current institutional shareholding score of Stoke Therapeutics Inc is 10.00, ranking 1 out of 386 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 118.29%, representing a quarter-over-quarter decrease of 3.39%. The largest institutional shareholder is John Hussman, holding a total of 87.12K shares, representing 0.13% of shares outstanding, with 3.63% decrease in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

RTW Investments L.P.

5.55M

+8.26%

Lynx1 Capital Advisors LLC

5.40M

Fidelity Management & Research Company LLC

4.75M

-19.92%

Redmile Group, LLC

4.03M

-3.39%

Morgan Stanley & Co. LLC

3.49M

+0.50%

BlackRock Institutional Trust Company, N.A.

3.44M

+4.09%

Baker Bros. Advisors LP

3.34M

-27.99%

TD Securities, Inc.

3.17M

State Street Investment Management (US)

2.50M

+75.19%